109 filings
ARS
2023 FY
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Annual report to shareholders
8:36am
DEFA14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Additional proxy soliciting materials
8:31am
DEF 14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Definitive proxy
8:24am
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
EFFECT
CTCX
Carmell Corp - Ordinary Shares
4 Jun 24
Notice of effectiveness
12:15am
D
eoyew046r26y2idmr9hm
30 Apr 24
$3.00 mm in equity, sold $3.00 mm, 19 investors
10:36am
8-K
kmao6lkgbyqw2e 1j
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
vrz9q bvkm78c9mz
1 Apr 24
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
4:47pm
8-K
xuej 2jjb35og1870
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
r3vy6b
16 Jan 24
Carmell Corp Announces Addition of Dr. Bradley Calobrace to Scientific Advisory Board
7:27pm
8-K
ygvgvlt0jh4xp2ahfsl
16 Jan 24
Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board
7:14pm
8-K
0nv5d1iyqhh4o
16 Jan 24
Carmell Corp Announces Addition of Dr. Gregory A. Buford to Scientific Advisory Board
7:07pm
8-K/A
xuneeubtbj7 h9fq1
16 Jan 24
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
7:06pm
8-K/A
6e2fvl9dkzi2auxil 8t
16 Jan 24
Carmell Corp Announces Addition of Dr. Jason D. Bloom to Scientific Advisory Board
6:51pm
8-K
k186iz9p
16 Jan 24
Carmell Corp Announces Addition of Dr. Adam Rubinstein to Scientific Advisory Board
6:06pm